Emer Cooke, EMA executive director (Martial Trazzini/Shutterstock)
Rare blood clot events more common among women receiving AstraZeneca Covid-19 vaccine, EMA says
The EMA is sticking with its statement that AstraZeneca’s Covid-19 vaccine is safe and effective, but the agency also discussed new data showing that younger …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
